Association of genetic variants in SEMA3F, CLEC16A, LAMA3, and PCSK2 with myocardial infarction in Japanese individuals

Atherosclerosis

Volumn 210, Issue 2, 2010, Pages 468-473

  Fujimaki, Tetsuo ^a   Kato, Kimihiko ^a   Yokoi, Kiyoshi ^a   Oguri, Mitsutoshi ^b   Yoshida, Tetsuro ^c   Watanabe, Sachiro ^d   Metoki, Norifumi ^e   Yoshida, Hidemi ^f   Satoh, Kei ^f   Aoyagi, Yukitoshi ^g   Nozawa, Yoshinori ^h   Kimura, Genjiro ⁱ   Yamada, Yoshiji ^j  

^a GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c Inabe General Hospital   (Japan)

^d GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^e Hirosaki Stroke Center   (Japan)

^f HIROSAKI UNIVERSITY   (Japan)

^g TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^h GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

ⁱ NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^j MIE UNIVERSITY   (Japan)

more..

Author keywords

Atherosclerosis; Coronary heart disease; Genetics; Myocardial infarction; Polymorphism

Indexed keywords

GENE PRODUCT; PROPROTEIN CONVERTASE 2; PROTEIN CLEC16A; PROTEIN LAMA3; SEMAPHORIN 3F; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME; HEART INFARCTION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

AGED; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIATION; HUMANS; JAPAN; LAMININ; LECTINS, C-TYPE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROPROTEIN CONVERTASE 2;

EID: 77953230914     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.11.050     Document Type: Article

References (29)

1. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
2. Kullo I.J., Ding K. Mechanisms of disease: the genetic basis of coronary heart disease. Nat Clin Pract Cardiovasc Med 2007, 4:558-569.
3. Arnett D.K., Baird A.E., Barkley R.A., et al. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2007, 115:2878-2901.
4. Erdmann J., Grosshennig A., Braund P.S., et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009, 41:280-282.
5. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
6. Myocardial Infarction Genetics Consortium Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009, 41:334-341.
7. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007, 357:443-453.
8. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316:1488-1491.
9. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316:1491-1493.
10. Yamada Y., Fuku N., Tanaka M., et al. Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis 2009, 207:144-149.
11. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002, 347:1916-1923.
12. Yamada Y., Kato K., Oguri M., et al. Genetic risk for myocardial infarction determined by polymorphisms of candidate genes in a Japanese population. J Med Genet 2008, 45:216-221.
13. Yamada Y., Matsuo H., Segawa T., et al. Assessment of genetic risk for myocardial infarction. Thromb Haemost 2006, 96:220-227.
14. Itoh Y., Mizuki N., Shimada T., et al. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005, 57:717-729.
15. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B 1995, 57:289-300.
16. Bielenberg D.R., Klagsbrun M. Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Rev 2007, 26:421-431.
17. Kawasaki Y., Kubomoto A., Yamasaki H. Control of intracellular localization and function of Cx43 by SEMA3F. J Membr Biol 2007, 217:53-61.
18. Severs N.J., Rothery S., Dupont E., et al. Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech 2001, 52:301-322.
19. Blackburn J.P., Peters N.S., Yeh H.I., et al. Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1995, 15:1219-1228.
20. Skinningsrud B., Husebye E.S., Pearce S.H., et al. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J Clin Endocrinol Metab 2008, 93:3310-3317.
21. Todd J.A., Walker N.M., Cooper J.D., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39:857-864.
22. Hakonarson H., Grant S.F., Bradfield J.P., et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007, 448:591-594.
23. Ryan M.C., Lee K., Miyashita Y., et al. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 1999, 145:1309-1323.
24. Tzu J., Marinkovich M.P. Bridging structure with function: structural, regulatory, and developmental role of laminins. Int J Biochem Cell Biol 2008, 40:199-214.
25. Seidah N.G., Chretien M., Day R. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie 1994, 76:197-209.
26. Rouille Y., Westermark G., Martin S.K., et al. Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells. Proc Natl Acad Sci USA 1994, 91:3242-3246.
27. Smeekens S.P., Montag A.G., Thomas G., et al. Proinsulin processing by the subtilisin-related proprotein convertases furin PC2, and PC3. Proc Natl Acad Sci USA 1992, 89:8822-8826.
28. Yoshida H., Ohagi S., Sanke T., et al. Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes 1995, 44:389-393.
29. Leak T.S., Keene K.L., Langefeld C.D., et al. Association of the proprotein convertase subtilisin/kexin-type 2 (PCSK2) gene with type 2 diabetes in an African American population. Mol Genet Metab 2007, 92:145-150.